Clinical impact of left ventricular hypertrophy and implications for regression
- PMID: 19732607
- DOI: 10.1016/j.pcad.2009.05.002
Clinical impact of left ventricular hypertrophy and implications for regression
Abstract
Left ventricular hypertrophy (LVH) is an independent risk factor and predictor of cardiovascular (CV) events and all-cause mortality. Patients with LVH are at increased risk for stroke, congestive heart failure, coronary heart disease, and sudden cardiac death. Left ventricular hypertrophy represents both a manifestation of the effects of hypertension and other CV risk factors over time as well as an intrinsic condition causing pathologic changes in the CV structure and function. We review the risk factors for LVH and its consequences, concentric remodeling, and its prognostic significance, clinical benefits and supporting evidence for LVH regression, and its implications for management. We conclude our review summarizing the various pharmacological and nonpharmacological therapeutic options approved for the treatment of hypertension and LVH regression and the supporting clinical trial data for these therapeutic strategies.
Similar articles
-
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.Herz. 2006 Jun;31(4):305-16. doi: 10.1007/s00059-006-2819-5. Herz. 2006. PMID: 16810470 Review.
-
Cardiac consequences of hypertension in hemodialysis patients.Semin Dial. 2004 Jul-Aug;17(4):299-303. doi: 10.1111/j.0894-0959.2004.17331.x. Semin Dial. 2004. PMID: 15250922 Review.
-
Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.J Cardiovasc Pharmacol. 1993;22 Suppl 1:S7-13. J Cardiovasc Pharmacol. 1993. PMID: 7507540 Review.
-
Left ventricular hypertrophy as a risk factor in hypertension.Afr J Med Med Sci. 1996 Sep;25(3):277-83. Afr J Med Med Sci. 1996. PMID: 10457806 Review.
-
[Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].Schweiz Med Wochenschr. 1993 Jan 30;123(4):99-107. Schweiz Med Wochenschr. 1993. PMID: 7678943 Review. German.
Cited by
-
Blood pressure, left ventricular geometry, and systolic function in children exposed to inorganic arsenic.Environ Health Perspect. 2015 Jun;123(6):629-35. doi: 10.1289/ehp.1307327. Epub 2015 Feb 27. Environ Health Perspect. 2015. PMID: 25738397 Free PMC article.
-
βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.J Mol Cell Cardiol. 2011 Oct;51(4):479-84. doi: 10.1016/j.yjmcc.2010.10.020. Epub 2010 Oct 28. J Mol Cell Cardiol. 2011. PMID: 21035454 Free PMC article. Review.
-
Heart disease is still a primary emphasis.Ochsner J. 2009 Winter;9(4):173-4. Ochsner J. 2009. PMID: 21603440 Free PMC article. No abstract available.
-
Childhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.J Child Neurol. 2012 Sep;27(9):1095-120. doi: 10.1177/0883073812448840. Epub 2012 Aug 1. J Child Neurol. 2012. PMID: 22859693 Free PMC article.
-
Fluid overload is a determinant for cardiac structural and functional impairments in type 2 diabetes mellitus and chronic kidney disease stage 5 not undergoing dialysis.PLoS One. 2020 Jul 30;15(7):e0235640. doi: 10.1371/journal.pone.0235640. eCollection 2020. PLoS One. 2020. PMID: 32730268 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
